Literature DB >> 9863597

Segregation of mutations in arylsulphatase E and correlation with the clinical presentation of chondrodysplasia punctata.

L J Sheffield1, A H Osborn, W M Hutchison, D O Sillence, S M Forrest, S J White, H H Dahl.   

Abstract

Sixteen males and two females with symmetrical (mild) type of chondrodysplasia punctata were tested for mutations in the X chromosome located arylsulphatase D and E genes. We identified one nonsense and two missense mutations in the arylsulphatase E gene in three males. No mutations were detected in the arylsulphatase D gene. Family studies showed segregation of the mutant genes establishing X linked inheritance for these families. Asymptomatic females and males were found in these studies. The clinical presentation varies not only between unrelated affected males, but also between affected males within the same family. We also conclude that clinical diagnosis of chondrodysplasia punctata in adults can be difficult. Finally, our results indicate that brachytelephalangy is not necessarily a feature of X linked symmetrical chondrodysplasia punctata.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9863597      PMCID: PMC1051512          DOI: 10.1136/jmg.35.12.1004

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  12 in total

1.  Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction.

Authors:  M Orita; Y Suzuki; T Sekiya; K Hayashi
Journal:  Genomics       Date:  1989-11       Impact factor: 5.736

Review 2.  Chondrodysplasia punctata: a boy with X-linked recessive chondrodysplasia punctata due to an inherited X-Y translocation with a current classification of these disorders.

Authors:  E A Wulfsberg; J Curtis; C H Jayne
Journal:  Am J Med Genet       Date:  1992-07-15

3.  Isolation and characterization of a steroid sulfatase cDNA clone: genomic deletions in patients with X-chromosome-linked ichthyosis.

Authors:  A Ballabio; G Parenti; R Carrozzo; G Sebastio; G Andria; V Buckle; N Fraser; I Craig; M Rocchi; G Romeo
Journal:  Proc Natl Acad Sci U S A       Date:  1987-07       Impact factor: 11.205

4.  Heterogeneity of Chondrodysplasia punctata.

Authors:  J W Spranger; J M Opitz; U Bidder
Journal:  Humangenetik       Date:  1971

5.  Mucopolysaccharidosis VI (Maroteaux-Lamy syndrome). An intermediate clinical phenotype caused by substitution of valine for glycine at position 137 of arylsulfatase B.

Authors:  G Wicker; V Prill; D Brooks; G Gibson; J Hopwood; K von Figura; C Peters
Journal:  J Biol Chem       Date:  1991-11-15       Impact factor: 5.157

6.  Brachytelephalangic chondrodysplasia punctata: a possible X-linked recessive form.

Authors:  P Maroteaux
Journal:  Hum Genet       Date:  1989-05       Impact factor: 4.132

7.  Chondrodysplasia punctata-23 cases of a mild and relatively common variety.

Authors:  L J Sheffield; D M Danks; V Mayne; A L Hutchinson
Journal:  J Pediatr       Date:  1976-12       Impact factor: 4.406

8.  A topoisomerase II cleavage site is associated with a novel mitochondrial DNA deletion.

Authors:  R B Blok; D R Thorburn; G N Thompson; H H Dahl
Journal:  Hum Genet       Date:  1995-01       Impact factor: 4.132

9.  A cluster of sulfatase genes on Xp22.3: mutations in chondrodysplasia punctata (CDPX) and implications for warfarin embryopathy.

Authors:  B Franco; G Meroni; G Parenti; J Levilliers; L Bernard; M Gebbia; L Cox; P Maroteaux; L Sheffield; G A Rappold; G Andria; C Petit; A Ballabio
Journal:  Cell       Date:  1995-04-07       Impact factor: 41.582

10.  X-linked recessive chondrodysplasia punctata due to a new point mutation of the ARSE gene.

Authors:  G Parenti; P Buttitta; G Meroni; B Franco; L Bernard; M G Rizzolo; N Brunetti-Pierri; A Ballabio; G Andria
Journal:  Am J Med Genet       Date:  1997-12-12
View more
  1 in total

1.  Brachytelephalangic chondrodysplasia punctata caused by new small hemizygous deletion in a boy presenting with hearing loss.

Authors:  Irena Vrečar; Gorazd Rudolf; Borut Peterlin; Luca Lovrecic
Journal:  Mol Cytogenet       Date:  2015-10-31       Impact factor: 2.009

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.